Lung Cancer Clinical Trials in Boston

Showing 541-553 of 553 trials

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

NCT00397293

This is an open label, multicenter Phase I/II study to evaluate the safety and efficacy of AT-101 in combination with topotecan in relapsed/refractory small cell lung cancer

Small Cell Lung Cancer

Ascenta Therapeutics36 participantsStarted Nov 2006

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • Loma Linda, California, United States +16 more locations

COMPLETEDPhase 2< 1 mile

Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer

NCT00165334

The purpose of this study is it to determine how well patients with non-small cell lung cancer respond to cetuximab plus vinorelbine. We would also like to determine the safety of cetuximab plus vinorelbine in people 70 years of age or older with advanced non-small cell lung cancer.

Non-small Cell Lung Cancer

Dana-Farber Cancer Institute53 participantsStarted Jun 2005

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer

Lung Cancer Trials in Other Cities

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Study of Picoplatin Efficacy After Relapse

Other Conditions in Boston